Skip to main content

MMB-CHMINACA

ADVERTISEMENT
Identification
Molecular formula
C23H30N4O2
CAS number
1971007-92-7
IUPAC name
1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide
State
State

At room temperature, MMB-CHMINACA is typically found in a solid state.

Melting point (Celsius)
151.00
Melting point (Kelvin)
424.00
Boiling point (Celsius)
121.00
Boiling point (Kelvin)
394.00
General information
Molecular weight
382.49g/mol
Molar mass
382.4910g/mol
Density
1.2000g/cm3
Appearence

MMB-CHMINACA appears as a crystalline solid with a pale-white to off-white coloration.

Comment on solubility

Solubility of 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide

The solubility of 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide (C23H30N4O2) can be characterized by several intriguing factors:

  • Polarity: The compound's molecular structure suggests moderate polar characteristics due to the presence of functional groups such as the carboxamide.
  • Solvent Interaction: It typically exhibits improved solubility in polar solvents such as dimethyl sulfoxide (DMSO) and ethanol.
  • Hydrophobic Effects: However, due to its relatively large hydrophobic regions from the bicyclic structure, solubility may decrease in non-polar solvents.

It is important to note that solubility can be influenced by various parameters, including:

  1. Temperature: Higher temperatures generally increase solubility.
  2. pH Levels: Changes in pH can affect the ionization of the carboxamide moiety, influencing overall solubility.
  3. Presence of Other Solutes: The presence of other solutes can lead to solubilization or precipitation effects.

In summary, when working with 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide, understanding its solubility profile is crucial for applications in pharmaceutical development and formulation.

Interesting facts

Interesting Facts about 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide

This fascinating compound brings together a unique combination of features that intrigue both chemists and medicinal researchers. With its complex structure, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide can be seen as a synthesizing marvel.

Key Features:

  • Structural Complexity: The bicyclic framework of this compound stands out, showcasing the innovative design often encountered in synthetic organic chemistry.
  • Pharmacological Potential: The indazole moiety is known for its interesting biological activity, with compounds like these often being explored for their potential therapeutic uses.
  • Design Insights: The inclusion of nitrogen atoms within the structure hints at possible interactions with biological systems, opening pathways for drug design in specific receptor targeting.

One of the most remarkable aspects of this compound is its capability of mimicking natural products, making it a candidate for further research in pharmacology. Scientists often say, "Innovation in chemical design leads to discovery in therapeutic applications," highlighting the importance of such complex compounds in modern medicine.

As researchers delve deeper into the properties and efficacy of this compound, it may one day contribute significantly to advancements in drug development, showcasing the vital role that structural chemistry plays in the pharmaceutical industry.

Synonyms
[3H]-granisetron
exo-Granisetron (Granisetron Impurity F)
[3H]GRANISETRON
Granisetron-d3
1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide
[3H]-BRL-43694
1364914-39-5
(3H)granisetron
Granisetronum [INN-Latin]
(3H)-granisetron
BRL 43694
1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1h-indazole-3-carboxamide
1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide
1-Methyl-N-{9-methyl-9-azabicyclo[3.3.1]nonan-3-yl}-1H-indazole-3-carboxamide
1224925-64-7
Granisetron base
1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-7-yl)indazole-3-carboxamide
(3H)-BRL-43694
124998-65-8
APF-530
1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)nonan-7-yl)indazole-3-carboxamide
GRAN
1-Methyl-N-[(3-endo)-9-(methyl-d3)-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide
SCHEMBL445223
CHEMBL289469
CHEMBL519643
GTPL2292
DTXSID50861188
CHEBI:184693
MFWNKCLOYSRHCJ-UHFFFAOYSA-N
BCP10022
EX-A1291
HY-B0071
ZYB92564
ZYB92576
BBL036319
BDBM50000483
PDSP1_001266
PDSP2_001250
STL483411
AKOS015895362
AB07494
CS-1509
SDCCGSBI-0633801.P001
NCGC00186041-01
NCGC00186041-09
LS-14665
NS00001739
AB01274752-01
AB01274752_02
AB01274752_03
L000281
BRD-A10967948-003-05-5
BRD-A10967948-003-06-3
1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide
1-Methyl-1H-indazole-3-carboxylic acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide
1-methyl-N-((1S,5R)-9-methyl-9-aza-bicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide
(BRL 43694)1-Methyl-1H-indazole-3-carboxylic acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide
(granisetron)1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide
1-(Methyl-d3)-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide
1-Methyl-1H-indazole-3-carboxylic acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide(BRL 43694)
1-Methyl-1H-indazole-3-carboxylic acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide(Granisetron)
2-(9-Methyl-3,9-diaza-bicyclo[3.3.1]non-3-yl)-1-(1-methyl-1H-indol-3-yl)-ethanone(Granisetron)